Literature DB >> 27073718

MicroRNA-373 promotes migration and invasion in human esophageal squamous cell carcinoma by inhibiting TIMP3 expression.

Wenzhi Liu1, Mengkao Li2, Xiangming Chen3, Dakai Zhang4, Lin Wei3, Zicheng Zhang5, Shuang Wang3, Li Meng3, Shan Zhu4, Baosheng Li3.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is the predominant pathological type of esophageal carcinoma in Asia. MicroRNAs (miRNAs) are a class of 19-22-nucleotide non-coding RNAs acting on target mRNAs that function as either oncogenes or anti-oncogenes. It has been confirmed that miR-373 expression varies among different tumor types. However, its mechanism is still unclear in ESCC. In our current study, we found that miR-373 expression was upregulated in ESCC tissues compared with matched adjacent normal tissues, as well as in the plasma of ESCC patients compared with that of healthy volunteers. Overexpression of miR-373 in ECA109 cells enhanced proliferation, G1-phase cell proportion, migration, and invasion. On the other hand, suppression of miR-373 in KYSE410 cells decreased proliferation, G1-phase cell proportion, migration, and invasion and also improved cell apoptosis. Moreover, we found that TIMP3, which was reported to suppress invasion and metastasis of ESCC, was a direct target of miR-373. Overexpression of miR-373 in ECA109 caused a reduction of TIMP3 mRNA and protein, whereas suppression of miR-373 in KYSE410 led to an increase of TIMP3 mRNA and protein. Introducing TIMP3 in miR-373 over-expressed cells or knocking down TIMP3 in miR-373 suppressed cells could partially abrogate the effect of miR-373 on migration and invasion. Therefore, these results prove that as an oncogene, miRNA-373 would be an important and reliable biomarker for ESCC diagnosis and treatment by targeting TIMP3.

Entities:  

Keywords:  Esophageal cancer; TIMP3; microRNA-373; oncogene

Year:  2015        PMID: 27073718      PMCID: PMC4759392     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  41 in total

1.  Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.

Authors:  Hyang Sook Seol; Yoshimitsu Akiyama; Shu Shimada; Hee Jin Lee; Tae Im Kim; Sung Min Chun; Shree Ram Singh; Se Jin Jang
Journal:  Cancer Lett       Date:  2014-07-22       Impact factor: 8.679

2.  MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma.

Authors:  Nannan Wu; Xuyuan Liu; Xuemei Xu; Xingxing Fan; Min Liu; Xin Li; Qiping Zhong; Hua Tang
Journal:  FEBS J       Date:  2011-05-17       Impact factor: 5.542

3.  TIMP3 controls cell fate to confer hepatocellular carcinoma resistance.

Authors:  V Defamie; O Sanchez; A Murthy; R Khokha
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

4.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

5.  MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.

Authors:  Xiaohui Xu; Zhaoli Chen; Xiaohong Zhao; Jiwen Wang; Dapeng Ding; Zhen Wang; Fengwei Tan; Xiaogang Tan; Fang Zhou; Jian Sun; Nan Sun; Yibo Gao; Kang Shao; Ning Li; Bin Qiu; Jie He
Journal:  Biochem Biophys Res Commun       Date:  2012-03-17       Impact factor: 3.575

6.  Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism.

Authors:  Jian Hua Qi; Bela Anand-Apte
Journal:  Apoptosis       Date:  2015-04       Impact factor: 4.677

7.  Quantitative detection of TIMP-3 promoter hypermethylation and its prognostic significance in esophageal squamous cell carcinoma.

Authors:  Itasu Ninomiya; Kazuyuki Kawakami; Sachio Fushida; Takashi Fujimura; Hiroshi Funaki; Hiroyuki Takamura; Hirohisa Kitagawa; Hisatoshi Nakagawara; Hidehiro Tajima; Masato Kayahara; Tetsuo Ohta
Journal:  Oncol Rep       Date:  2008-12       Impact factor: 3.906

8.  Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.

Authors:  Mohammad Obaidul Hoque; Shahnaz Begum; Mariana Brait; Carmen Jeronimo; Marianna Zahurak; Kimberly Laskie Ostrow; Eli Rosenbaum; Bruce Trock; William H Westra; Mark Schoenberg; Steven N Goodman; David Sidransky
Journal:  J Urol       Date:  2007-12-20       Impact factor: 7.450

9.  Circulating microRNAs as specific biomarkers for breast cancer detection.

Authors:  Enders K O Ng; Rufina Li; Vivian Y Shin; Hong Chuan Jin; Candy P H Leung; Edmond S K Ma; Roberta Pang; Daniel Chua; Kent-Man Chu; W L Law; Simon Y K Law; Ronnie T P Poon; Ava Kwong
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

10.  miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.

Authors:  L Du; Z Zhao; X Ma; T-H Hsiao; Y Chen; E Young; M Suraokar; I Wistuba; J D Minna; A Pertsemlidis
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

View more
  11 in total

1.  CCR7 enhances the angiogenic capacity of esophageal squamous carcinoma cells in vitro via activation of the NF-κB/VEGF signaling pathway.

Authors:  Qing-Yong Cai; Gui-You Liang; Yi-Feng Zheng; Qun-You Tan; Ru-Wen Wang; Kun Li
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer.

Authors:  Feng Guo; Yang Luo; Yi-Fei Mu; Shao-Lan Qin; Yang Qi; Yi-Er Qiu; Ming Zhong
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

3.  Lack of Correlation between Aberrant p16, RAR-β2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation.

Authors:  Yui Terayama; Tetsuro Matsuura; Kiyokazu Ozaki
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 4.  Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.

Authors:  Xiaobin Hou; Jiaxin Wen; Zhipeng Ren; Guoliang Zhang
Journal:  Oncotarget       Date:  2017-06-27

5.  miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Authors:  Wan Li; Jie Yi; Xiangjin Zheng; Shiwei Liu; Weiqi Fu; Liwen Ren; Li Li; Dave S B Hoon; Jinhua Wang; Guanhua Du
Journal:  Clin Epigenetics       Date:  2018-05-16       Impact factor: 7.259

Review 6.  Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology.

Authors:  Dong Fan; Zamaneh Kassiri
Journal:  Front Physiol       Date:  2020-06-16       Impact factor: 4.566

7.  miR-222-3p promotes osteosarcoma cell migration and invasion through targeting TIMP3.

Authors:  Jianping Guo; Quanxiang Liu; Zengxin Li; Haifeng Guo; Changshuang Bai; Fajia Wang
Journal:  Onco Targets Ther       Date:  2018-12-03       Impact factor: 4.147

8.  Ginsenoside Rh1 inhibits colorectal cancer cell migration and invasion in vitro and tumor growth in vivo.

Authors:  Xi Lyu; Xiaodong Xu; Ailin Song; Jinyi Guo; Yawu Zhang; Youcheng Zhang
Journal:  Oncol Lett       Date:  2019-08-14       Impact factor: 2.967

9.  MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.

Authors:  Feng Wang; Jun Wang; Xuan Yang; Danjie Chen; Liuxing Wang
Journal:  Diagn Pathol       Date:  2016-09-15       Impact factor: 2.644

10.  Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation.

Authors:  Jimi L Rosenkrantz; Jessica E Gaffney; Victoria H J Roberts; Lucia Carbone; Shawn L Chavez
Journal:  BMC Biol       Date:  2021-06-21       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.